Document Detail


Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk.
MedLine Citation:
PMID:  15699689     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Human milk components, including oligosaccharides, affect the gastrointestinal flora of infants. Previous studies in adults have demonstrated that fructo-oligosaccharides increase potentially beneficial fecal bacteria, including bifidobacteria. The purpose of this study was to determine the prebiotic effect of infant formula supplemented with fructo-oligosaccharides. METHODS: Healthy term infants 2 to 6 weeks of age were enrolled in a 5-week, prospective, randomized, crossover, single-site study with a nonrandomized human milk comparator group. Washout weeks preceded and followed a week of feeding with fructo-oligosaccharide-supplemented formula (1.5 or 3.0 g/L). Stool specimens were quantitatively cultured weekly for bacteroides, lactobacilli, bifidobacteria, clostridia and enterococci and were tested for Clostridium difficile toxin. RESULTS: Seventy-two of 87 infants completed the trial; 58 were formula fed and 14 were human milk fed. Mean counts of bifidobacteria and lactobacilli were similar in all groups at entry and no group experienced a significant change in counts with fructo-oligosaccharide supplementation. After 7 days of fructo-oligosaccharide supplementation the bifidobacteria counts were greater in the 1.5 g/L fructo-oligosaccharide formula group than in the human milk fed or 3.0 g/L fructo-oligosaccharide formula groups. Formula-fed infants had higher counts of enterococci and bacteroides before fructo-oligosaccharide supplementation, and these counts did not change after supplementation. Clostridium counts increased 7 days after supplementation in the 1.5 g/L fructo-oligosaccharide formula group (P = 0.0356). No human milk fed infants had C. difficile toxin in stools. Fructo-oligosaccharide (3.0 g/L) supplementation resulted in more frequent and significantly softer stools. CONCLUSIONS: Infant formula supplemented with 1.5 or 3.0 g/L fructo-oligosaccharides was safe but had minimal effect on fecal flora and C. difficile toxin.
Authors:
Arthur R Euler; Douglas K Mitchell; Randi Kline; Larry K Pickering
Related Documents :
3876419 - Serial serum 25-hydroxyvitamin d and mineral homeostasis in very premature infants fed ...
10617979 - Essential fat requirements of preterm infants.
2622129 - Plasma apolipoprotein and lipid profiles in infants in the first year of life.
3639729 - Carbohydrate derived energy and gross energy absorption in preterm infants fed human mi...
3812339 - Storage of medium-chain triglycerides in adipose tissue of orally fed infants.
16786869 - Gamma radiation sensitivity of enterobacter sakazakii in dehydrated powdered infant for...
17766499 - Functional outcomes and participation in young adulthood for very preterm and very low ...
7215119 - Placental tissue registry. analysis of the first 500 cases.
8006559 - Acarboxy prothrombin (pivka-ii) in cord plasma in the south of thailand.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of pediatric gastroenterology and nutrition     Volume:  40     ISSN:  0277-2116     ISO Abbreviation:  J. Pediatr. Gastroenterol. Nutr.     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-02-08     Completed Date:  2005-06-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8211545     Medline TA:  J Pediatr Gastroenterol Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  157-64     Citation Subset:  IM    
Affiliation:
Wyeth Nutrition, Collegeville, Pennsylvania, USA. a.euler@insightbb.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bifidobacterium / drug effects,  growth & development*
Colony Count, Microbial
Cross-Over Studies
Dose-Response Relationship, Drug
Enterotoxins / analysis*,  isolation & purification
Feces / microbiology*
Female
Humans
Infant
Infant Formula*
Infant, Newborn
Male
Milk, Human* / chemistry,  microbiology
Oligosaccharides / administration & dosage*
Probiotics / administration & dosage*
Prospective Studies
Chemical
Reg. No./Substance:
0/Enterotoxins; 0/Idolax; 0/Oligosaccharides; 0/enterotoxin, Clostridium
Comments/Corrections
Comment In:
Pediatr Endocrinol Rev. 2005 Jun;2(4):683-4   [PMID:  16208282 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dietary unsaturated long-chain Fatty acids modify D-glucose absorption in weaning rats.
Next Document:  Antiendomysial antibody detection in biopsy culture allows avoidance of gluten challenge in celiac c...